Dlin-MeOH

CAS No. 1169768-28-8

Dlin-MeOH( —— )

Catalog No. M36591 CAS No. 1169768-28-8

Dlin-MeOH is a lipid membrane and a potential nucleic acid carrier for the synthesis of DLin-MC3-DMA.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 56 In Stock
2MG 31 In Stock
5MG 48 In Stock
10MG 80 In Stock
25MG 155 In Stock
50MG 239 In Stock
100MG 369 In Stock
200MG Get Quote In Stock
500MG 870 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dlin-MeOH
  • Note
    Research use only, not for human use.
  • Brief Description
    Dlin-MeOH is a lipid membrane and a potential nucleic acid carrier for the synthesis of DLin-MC3-DMA.
  • Description
    Dlin-MeOH is a lipid product for use in drug delivery systems.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1169768-28-8
  • Formula Weight
    528.94
  • Molecular Formula
    C37H68O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (189.06 mM; Ultrasonic )
  • SMILES
    C(C(CCCCCCCC/C=C\C/C=C\CCCCC)O)CCCCCCC/C=C\C/C=C\CCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hideyoshi H,et al. Lipid membrane structure suitable for use for siRNA delivery containing linoleic acid-derived pH-responsive lipid. JP2016084297.
molnova catalog
related products
  • Sodefrin

    Sodefrin

  • N-(3-Indolylacetyl)g...

    Indole-3-acetylglycine is a biochemical assay reagent.

  • Amatuximab

    Amatuximab (MORab-009) is a humanized chimeric IgG1/k monoclonal antibody targeting cell surface mesothelin (MSLN) with antitumor activity for the treatment of solid tumors.